Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines.

World J Gastroenterol

Renji Hospital, Shanghai Second Medical University, Shanghai Institute of Digestive Disease, Shanghai 200001, China.

Published: September 2004

Aim: To investigate the effect of histone acetylation on regulation of p21WAF1 gene expression in human colon cancer cell lines.

Methods: Two cell lines, Colo-320 and SW1116 were treated with either trichostatin or sodium butyrate. Expressions of p21WAF1 mRNA and protein were detected by real-time RT-PCR and Western blotting, respectively. Acetylation of two regions of p21WAF1 gene-associated histones and total cellular histones were examined by chromatin immunoprecipitation assay and Western blotting.

Results: Trichostatin or sodium butyrate re-activated p21WAF1 transcription resulted in up-regulated p21WAF1 protein level in colon cancer cell lines. Those effects were accompanied by an accumulation of acetylated histones in total cellular chromatin and p21WAF1 gene-associated region of chromatin.

Conclusion: Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines, Colo-320 and SW1116.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572185PMC
http://dx.doi.org/10.3748/wjg.v10.i18.2643DOI Listing

Publication Analysis

Top Keywords

colon cancer
16
cancer cell
16
cell lines
16
histone acetylation
12
expression human
12
human colon
12
acetylation regulates
8
p21waf1
8
regulates p21waf1
8
p21waf1 expression
8

Similar Publications

Purpose: Identifying therapeutic targets for Signet Ring Cell Carcinoma (SRCC) of the colon and rectum is a clinical challenge due to the lack of Patient-Derived Organoids (PDO) or Xenografts (PDX). We present a robust method to establish PDO and PDX models to answer address this unmet need. We demonstrate that these models identify novel therapeutic strategies targeting therapy resistance and peritoneal metastasis.

View Article and Find Full Text PDF

Purpose: This meta-analysis aims to estimate the global prevalence of severe, moderate, overall malnutrition and moderating factors of malnutrition in colorectal cancer (CRC) survivors.

Methods: A comprehensive search was conducted in Embase, CINAHL, Medline-OVID, PubMed, Scopus, and Web of Science from inception to February 8, 2024, without language, region, or publication date restrictions. A generalized linear mixed model and random-effects model were used to examine the pooled prevalence, and moderator analyses were implemented to investigate variations in the pooled prevalence.

View Article and Find Full Text PDF

Aim: To construct a predictive model based on the LODDS stage established for patients with late-onset colon adenocarcinoma to enhance survival stratification.

Methods: Late-onset colon adenocarcinoma data were obtained from the public database. After determining the optimal LODDS truncation value for the training set via X-tile software, we created a new staging system by integrating the T stage and M stage.

View Article and Find Full Text PDF

Decoding the RELARC trial - is D2 dissection sufficient in right colon cancer?

ANZ J Surg

January 2025

Colorectal Unit, Department of General Surgery, The Alfred, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!